definiens: ) to license New Indication is defined as the use of licensed Patent Rights, Tangible Research Property and Techni cal Information for medical diagnostics and prognostics in the field of breast cancer, colon cancer or gastric carcinoma arising from research performed by or under the direction of [ * * * ], during the [ * * * ] ( [ * * * ] ) month period following the Effective Date of this Agreement . Licensee will provide a written notification to WUSTL notifying of its intention to exercise the IP Option . Licensee and WUSTL shall negotiate 1 ) an exclusive license in good faith for a period of [ * * * ] ( [ * * * ] ) days for patents and paten t applications ; and/or 2 ) a non -exclusive license for Tangible Research Property and Technical Information . If Licensee does not exercise the IP Option within the [ * * * ] ( [ * * * ] ) month period, the IP Option shall terminate with respect to such New Indication and WUSTL shall be free to license such New Indication to any third party subject to Licensee ’s rights under Section 2.1 . This section 2.1.1 notwithstanding, WUSTL will be free to use and provide Patent Rights, Tangible Research Property and Technical Inf ormation for the New Indication to other not -for - profit or academic entities for research and educational purposes